tert-Butyl 4-benzoylpiperidine-1-carboxylate

CAS : 193217-39-9

Ref. 3D-THA21739

Informations sur le produit

• Nom: tert-Butyl 4-benzoylpiperidine-1-carboxylate

Description

Tert-butyl 4-benzoylpiperidine-1-carboxylate (TBCPC) is a novel amide antagonist that has been shown to inhibit HIV entry into cells. TBCPC has been shown to have an oral bioavailability of 100% and a half-life of 10 hours in rats. This compound also had no effect on the pharmacokinetic profile of other drugs, which could make it a good candidate for replacing other anti-HIV drugs. TBCPC has the potential to be developed as a ccr5 antagonist and may have potential applications in treating diseases such as cancer, inflammatory bowel disease, and AIDS.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 289.37 g/mol
• Formule: C₁₇H₂₃NO₃
• Degré de pureté: Min. 95%